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Candida albicans is the most common human yeast pathogen which causes mucosal
infections and invasive fungal diseases. Early detection of this pathogen is needed to
guide preventative and therapeutic treatment. The aim of this study was to establish a
polymerase spiral reaction (PSR) assay that rapidly and accurately detects C. albicans
and to assess the clinical applicability of PSR-based diagnostic testing. Internal
transcribed spacer 2 (ITS2), a region between 5.8S and 28S fungal ribosomal DNA,
was used as the target sequence. Four primers were designed for amplification of
ITS2 with the PSR method, which was evaluated using real time turbidity monitoring
and visual detection using a pH indicator. Fourteen non-C. albicans yeast strains were
negative for detection, which indicated the specificity of PSR assay was 100%. A 10-
fold serial dilution of C. albicans genomic DNA was subjected to PSR and conventional
polimerase chain reaction (PCR) to compare their sensitivities. The detection limit of PSR
was 6.9 pg/µl within 1 h, 10-fold higher than that of PCR (69.0 pg/µl). Blood samples
(n = 122) were collected from intensive care unit and hematological patients with proven
or suspected C. albicans infection at two hospitals in Beijing, China. Both PSR assay
and the culture method were used to analyze the samples. Of the 122 clinical samples,
34 were identified as positive by PSR. The result was consistent with those obtained by
the culture method. In conclusion, a novel and effective C. albicans detection assay was
developed that has a great potential for clinical screening and point-of-care testing.
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INTRODUCTION
Candida albicans is an important human yeast pathogen that accounts for the majority of
superficial and systemic infections caused by the Candida genus (Fan et al., 2008; Sobel, 2015).
Candidemia, the most common form of systemic candidiasis, is the fourth most frequent cause of
nosocomial bloodstream infections with a mortality rate of about 50% (Gudlaugsson et al., 2003;
Kibbler et al., 2003). The morbidity of invasive candidiasis has been increasing in recent years due
to the widespread use of broad-spectrum antibiotics, hormone drugs, and immunosuppressants,
while invasive treatment such as endotracheal intubation and mechanically ventilation is also an
important risk factor (Kim and Sudbery, 2011; Tang et al., 2016). Because Candida spp. differ
in their patterns of resistance to common antifungals, differentiation of C. albicans from other
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TABLE 1 | Yeast strains included in the study.
Yeast strains Source
Candida albicans ATCC 24433 Our microorganism center
Candida. albicans ATCC 90028 Our microorganism center
C. albicans CGMCC 2.4159 Our microorganism center
C. glabrata ATCC 2001 Our microorganism center
C. tropicalis CGMCC 2.3967 Our microorganism center
C. parapsilosis CGMCC 2.3962 Our microorganism center
C. krusei CGMCC 2.1047 Our microorganism center
Cryptococcus neoformans ATCC 66031 Our microorganism center
C. metapsilosis ATCC 96144 Our microorganism center
Saccharomyces cerevisiae CGMCC 2.3889 Our microorganism center
Debaryomyces hansenii CGMCC 2.3948 Our microorganism center
Kluyveromyces marxianus CGMCC 2.3959 Our microorganism center
Metschnikowia pulcherrima CGMCC 2.3776 Our microorganism center
Pichia membranifaciens CGMCC 2.4060 Our microorganism center
P. anomala CGMCC 2.1819 Our microorganism center
Kluyveromyces marxianus CGMCC 2.3959 Our microorganism center
Trichosporon cutaneum CGMCC 2.2163 Our microorganism center
ATCC, American Type Culture Collection; CGMCC, China General Microbiological
Culture Collection Center.
Candida species is required for appropriate preventative
and antimicrobial therapy (Kim and Brehm-Stecher, 2015).
Moreover, the number of clinical C. albicans isolates resistant to
antifungal agents is on the rise (Liu et al., 2014). Therefore, early
and accurate identification of C. albicans is critical, especially in
patients with suspected symptoms of invasive candidiasis.
Conventional C. albicans detection methods based on
phenotype include blood culture, microscopic examination, and
biochemical identification (Bouchara et al., 1996; Alam et al.,
2014). However, they are time-consuming, labor-intensive with
low sensitivity. The long period of waiting time required to
diagnose C. albicans infection often leads to a delay in the
start of treatment with antifungal drugs. Additionally, several
molecular biological methods have been applied to the detection
of C. albicans, such as polimerase chain reaction (PCR; Holmes
et al., 1994; Vahidnia et al., 2015), real-time PCR (Guiver et al.,
2001; Maaroufi et al., 2003), mass spectrometry (Zehm et al.,
2012), and immunoassay (Gunasekera et al., 2015). Nevertheless,
these techniques are relatively complex and require expertise
and expensive instruments. Thus, a simpler, more cost-effective
method is needed.
Polymerase spiral reaction (PSR), a novel isothermal nucleic
acid testing (INAT) method based on auto cycling strand
displacement activity using Bst DNA polymerase, is characterized
by rapidity, high specificity and high sensitivity (Liu et al.,
2015). Different from PCR, which needs a strictly temperature-
controlled and sophisticated instrument, PSR is performed under
isothermal conditions. Thus, a thermostat water bath or metal
bath is sufficient to initiate the PSR reaction. Compared to other
established INAT techniques, PSR does not require an initial
incubation at high temperature or the utilization of a DNA
helicase in the reaction mix to attain the denaturation of DNA
double helix (Walker et al., 1992; Notomi et al., 2000). PSR
is being widely applied to the detection of bacteria, antibiotic
resistance genes, and viruses (Dong et al., 2015).
Internal transcribed spacer 2 (ITS2), a region between 5.8S
and 28S fungal ribosomal DNA (rDNA), is frequently used for
identification of fungal species (Turenne et al., 1999). In this
research, we designed primers targeting the ITS2 sequence and
determined the specificity and sensitivity of PSR detection for
C. albicans. Subsequently, the clinical applicability of the PSR
method for identifying C. albicans was evaluated in intensive care
unit (ICU) and hematological patients with proven or suspected
candidiasis infections.
MATERIALS AND METHODS
Ethics Statement
All volunteers provided written, informed consent to participate
in this study, which was reviewed and approved by the ethics
committee of the Academy of Military Medical Sciences, China.
Yeast Strains, Clinical Samples, and
Antifungal Susceptibility Testing
The yeast strains used in this study were listed in Table 1, with
three C. albicans strains serving as the positive control. Fourteen
non-C. albicans yeast strains were included as negative controls
in order to evaluate the specificity of the PSR method. During
the study period, 122 blood samples were collected from ICU
and hematological patients with proven or suspected C. albicans
infections at two comprehensive hospitals (301th hospital and
307th hospital) in Beijing, China. Besides, 10 blood samples from
healthy volunteers were included as controls. The samples were
analyzed by parallel examinations of PSR assay, PCR assay and
conventional blood culture at independent study sites. For blood
culture, briefly, all samples were evaluated in the BacT/Alert
3D blood culture system (BioMérieux, France). The positive
cultures were further inoculated on blood agar plates. Species
identification was conducted using the VITEK 2 automated
microbiology system (BioMérieux, France) and by sequencing
the ITS region of fungal rDNA (Turenne et al., 1999). Antifungal
susceptibility testing was carried out using commercialized ATB
FUNGUS 3 strips (BioMérieux, France). C. albicans ATCC 90028
was used as the quality-control strain.
DNA Extraction
DNA isolation from clinical blood samples was processed
according to a method described by Maaroufi (Maaroufi et al.,
2003). To evaluate the specificity and sensitivity of the PSR assay,
C. albicans ATCC 24433 and other yeast strains were cultured
in Sabouraud broth. Genomic DNA was extracted using the Dr.
GenTLE (from Yeast) High Recovery kit (Takara, Japan).
PSR Primer Design
Candida albicans-specific PSR primers were designed based on
the nucleotide sequence of ITS2 region obtained from the NCBI
GenBank database (Accession No. KP675666.1). The nucleotide
sequences of primers and their locations on ITS2 are shown in
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FIGURE 1 | polymerase spiral reaction (PSR) primer design for the detection of Candida albicans. (A) Locations of primers on the ITS2 region are
underlined. (B) Nucleotide sequence of primers.
FIGURE 2 | Temperature optimization of PSR assay. Different
temperatures were tested and 65◦C was chosen as the optimal temperature
for PSR amplification.
Figure 1. The uppercase sequences at the 3′-end of the forward
primer (F) and backward primer (B) were complementary to
the ITS2 region (position 282–299 and 437–417, respectively).
The lowercase sequences at the 5′-end of the backward primer
(T) were complementary to the ITS2 region (positions 359–379)
and was reverse to the lowercase sequences at the 5′-end of the
forward primer (Tr). Auxiliary primers, IF and IB (positions
323–304 and 402–416, respectively), were designed to enhance
the reaction velocity.
PSR Assay
Polymerase spiral reaction reactions were carried out at 65◦C
for 60 min in a final volume of 25 µl containing the following
FIGURE 3 | The specificity of PSR method. The PSR assay specificity for
C. albicans detection was evaluated by real-time turbidimeter (A) and the pH
indicator colorimetric assay (B). 1, C. albicans ATCC 24433; 2, C. albicans
ATCC 90028; 3, C. albicans CGMCC 2.4159; 4, Candida glabrata ATCC
2001; 5, Candida tropicalis CGMCC 2.3967; 6, Candida parapsilosis CGMCC
2.3962; 7, Candida krusei CGMCC 2.1047; 8, Cryptococcus neoformans
ATCC 66031; 9, Candida metapsilosis ATCC 96144; 10, Saccharomyces
cerevisiae CGMCC 2.3889; 11, Debaryomyces hansenii CGMCC 2.3948; 12,
Kluyveromyces marxianus CGMCC 2.3959; 13, Metschnikowia pulcherrima
CGMCC 2.3776; 14, Pichia membranifaciens CGMCC 2.4060; 15, Pichia
anomala CGMCC 2.1819; 16, Kluyveromyces marxianus CGMCC 2.3959;
17, Trichosporon cutaneum CGMCC 2.2163; 18, negative control
(double-distilled water).
components: 8 U of Bst DNA polymerase; 12.5 µl buffer solution
(pH 8.8, containing 20 mM (NH4)2SO4, 100 mM KCl, 16 mM
MgSO4, 1.6 M betaine, 0.2% Tween 20, and 2.8 mM of each
dNTP); and 2.0 µl DNA template. The amount of primers per
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FIGURE 4 | The sensitivity of PSR assay. Sensitivity of the PSR method (A,
B) versus conventional PCR (C) for the detection of C. albicans. 1–7, 10-fold
serial dilutions of C. albicans ATCC 24433 genomic DNA
(69.0 ng/µl–0.069 pg/µl); 8, double-distilled water.
reaction was 0.8 µM for IF and IB and 1.6 µM for Ft and
Bt. Finally, the reaction mixture was covered with a protectant
(patent: ZL201210371448.5, China) to prevent aerosol cross-
contamination.
Amplification was monitored by two methods, turbidity
monitoring with a real-time turbidimeter (LA-320c; Eiken
Chemical, Japan) and direct visual in the presence of pH dye.
A 1-µl volume of pH indicator (containing cresol red, 2.0 mM;
phenol red, 0.6 mM) was added to the reaction tube; the color
change from red to yellow for positive samples was visible by
naked eye under natural light, while the negative reaction stayed
red (Tanner et al., 2015). Each experiment was repeated at least
three times.
PCR Assay
The PCR method was conducted using primers SAP-F
(5′- CTGCTGATATTACTGTTGGTTC-3′) and SAP-B (5′-
CCACCAATACCAACGGTATC-3′). The reaction conditions
were in accordance with the previously published papers (Flahaut
et al., 1998). The expected PCR product size was 263 bp. The
products were separated by electrophoresis on a 1% agarose gel
TABLE 3 | Results of antifungal susceptibility testing of the 34 C. albicans
isolates.
Antifungal drug Sensitive (%) Intermediate (%) Resistant (%)
5-Fluorocytosine 91.2 0 8.8
Fluconazole 79.4 5.9 14.7
Voriconazole 70.6 11.8 17.6
Itraconazole 82.4 11.7 5.9
Amphotericin B 100 0 0
(Amresco, USA), which was stained by GelRed (Biotium, USA)
and imaged using the Gel Doc XR+ system (Bio-Rad, USA).
RESULTS
Temperature Optimization of PSR Assay
Reaction temperatures ranging from 63 to 67◦C at 1◦C
increments were compared for optimal amplification. As shown
in Figure 2, both 64 and 65◦C sets amplified the target
sequence within the shortest time. However, 65◦C is the optimal
temperature for the enzymatic activity of Bst DNA polymerase
(Aliotta et al., 1996) and was, therefore, chosen for the following
experiments.
Specificity of the PSR Assay
Candida albicans ATCC 24433, C. albicans ATCC 90028, and
C. albicans CGMCC 2.4159 were used as the positive control
and double-distilled water as the blank control when assessing
the specificity of PSR method for the detection of C. albicans.
In addition, 14 non-C. albicans yeast strains were tested. As
shown in Figure 3, both real-time turbidity monitoring and
visual detection correctly identified C. albicans. All other yeast
strains tested negative in addition to the blank control, indicating
that PSR assay can detect C. albicans with high specificity.
Comparison between the Sensitivities of
PSR and PCR for C. albicans Detection
To compare the sensitivities of the PSR method and conventional
PCR amplification, we conducted 10-fold serial dilutions of
C. albicans ATCC 24433 genomic DNA (69.0 ng/µl–0.069 pg/µl)
and subjected them to sensitivity testing. The detection limit for
PSR was 6.9 pg/µl based on either turbidity measurement or
visual inspection, 10-fold higher than that of conventional PCR
(Figure 4). The results indicated that PSR assay is highly sensitive
for the detection of C. albicans.
Clinical Application of the PSR Method
To assess the clinical applicability of the PSR method, we analyzed
122 blood samples from patients with proven or suspected
TABLE 2 | Comparison of the results obtained from clinical blood samples by the method of PSR, PCR and blood culture.
Total Positive by culture False negative by PSR False positive by PSR False negative by PCR False positive by PCR
No. of samples 132 34 0 0 2 0
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candidiasis infection by PSR, PCR and conventional blood
culture. Thirty-four samples were tested positive for C. albicans
by PSR (Table 2), in agreement with the culture method. There
were false-negative results by PCR assay with two samples. None
of the control samples from healthy volunteers was positive in
these methods. Sequence analyses of the ITS2 region from the 34
C. albicans isolates was conserved with the nucleotide sequences
reported previously. Antifungal susceptibility testing was carried
out to further characterize the clinical C. albicans isolates. The
susceptibility rate was 91.2% for 5-fluorocytosine, 79.4% for
fluconazole, 70.6% for voriconazole, and 82.4% for itraconazole;
none of the tested strains showed resistance to amphotericin B
(Table 3).
DISCUSSION
Normally living as a harmless commensal, C. albicans commonly
resides in mucosal surfaces of the gastrointestinal and
genitourinary tracts (Zucchi et al., 2010). However, overgrowth
of C. albicans will result in mucosal and superficial diseases
such as oral candidiasis and vulvo vaginal candidiasis (VVC).
Moreover, C. albicans can enter the systemic circulation through
epithelial tissue, causing critical invasive candidiasis such as
bloodstream infections, bronchopneumonia, and meningitis.
Unfortunately, early diagnosis of invasive candidiasis remains
a challenge because of unapparent symptoms (e.g., a prolonged
low-grade fever) and time-consuming fungal culture methods
(Tang et al., 2016). Thus, early and accurate identification of
C. albicans is very important.
The development of INAT methods has greatly facilitated
clinical screening and on-site diagnosis (Li and Macdonald,
2015). In this study, the PSR method, a recently developed INAT
technique, was used to detect C. albicans targeting the ITS2 gene.
Additionally, two auxiliary primers were designed to improve the
reaction velocity. When the Bst DNA polymerase incorporates
a deoxynucleoside triphosphate into the nascent DNA, the by-
products include a hydrogen ion (Pourmand et al., 2006). The
accumulation of hydrogen ions results in the decrease of pH
value, which enabled the use of pH indicator. Both continuous
monitoring with a real-time turbidimeter and visual inspection
with the aid of cresol red and phenol red were used to assess the
PSR amplification of the ITS2 gene, with an identical sensitivity
of 6.9 pg/µl within 60 min, which was 10 times more sensitive
than traditional PCR (69.0 pg/µl). Moreover, no false-positive
amplification was observed when testing non-C. albicans species.
The PSR method requires a constant-temperature
environment, so a thermostatic water bath or even a vacuum
cup is sufficient to perform the PSR reaction. In contrast, PCR
involves temperature cycling. It is also worth mentioning that
covering the reaction mixture with a wax seal was essential for
minimizing cross contamination, without disturbing the PSR
reaction.
The clinical applicability of PSR was confirmed through a
surveillance of C. albicans in blood samples. The test results
indicated that 34/122 of samples tested positive, which was in
coincidence with the culture method. However, the latter requires
at least 2–3 days, while it takes less than 60 min for PSR-based
detection. There were two false-negative results by PCR assay
(sensitivity: 94.1%), indicating PSR is more sensitive than PCR
for detection of samples with low C. albicans loads. In addition,
the PSR method is easy to operate and obviates the need for
complicated instruments. It is fast and convenient to identify
the result as positive or negative through color change. Thus,
we think PSR has a great potential for clinical screening. The
antifungal susceptibility testing of C. albicans isolates revealed
that amphotericin B may be beneficial when azole antifungal
agents are ineffective for VVC treatment.
CONCLUSION
We established a novel PSR detection method for C. albicans,
which meets the guidelines proposed by the World Health
Organization for developing diagnostic techniques—namely,
ASSURED (affordable, sensitive, specific, user-friendly, robust
and rapid, equipment-free, and deliverable; Mabey et al., 2004).
We anticipate its routine use for on-site testing in clinical settings,
especially in situations where resources are limited.
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